In addition, we observed that these PTHrP peptide-stimulated PBMCs from cancer patients showed cytotoxicity against another prostate cancer cells PC-93-A24, stably expressed the HLA-A24 molecules and produced PTHrP (data not shown). This evidence concerns the gene PTHLH and prostate carcinoma.